2023 Q2 Form 10-Q Financial Statement

#000162828023014793 Filed on May 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $6.075B $5.615B $4.199B
YoY Change 13.81% 33.72% 81.3%
Cost Of Revenue $4.653B $4.417B $3.376B
YoY Change 13.27% 30.84% 71.54%
Gross Profit $1.422B $1.198B $823.0M
YoY Change 15.61% 45.57% 136.49%
Gross Profit Margin 23.41% 21.34% 19.6%
Selling, General & Admin $240.0M $202.0M $208.0M
YoY Change 3.9% -2.88% -1.42%
% of Gross Profit 16.88% 16.86% 25.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $70.00M $65.00M $72.00M
YoY Change 2.94% -9.72% 4.35%
% of Gross Profit 4.92% 5.43% 8.75%
Operating Expenses $288.0M $246.0M $256.0M
YoY Change 2.86% -3.91% -2.66%
Operating Profit $1.134B $951.0M $558.0M
YoY Change 19.37% 70.43% 564.29%
Interest Expense -$132.0M $126.0M $93.00M
YoY Change -238.95% 35.48% -13.08%
% of Operating Profit -11.64% 13.25% 16.67%
Other Income/Expense, Net $2.000M $3.000M $4.000M
YoY Change 0.0% -25.0% 300.0%
Pretax Income $964.0M $844.0M $476.0M
YoY Change 9.79% 77.31% -1862.96%
Income Tax $238.0M $87.00M $99.00M
% Of Pretax Income 24.69% 10.31% 20.8%
Net Earnings $726.0M $757.0M $377.0M
YoY Change 7.08% 100.8% -3527.27%
Net Earnings / Revenue 11.95% 13.48% 8.98%
Basic Earnings Per Share $2.39 $2.44 $1.15
Diluted Earnings Per Share $2.38 $2.43 $1.14
COMMON SHARES
Basic Shares Outstanding 303.4M shares 308.1M shares 328.3M shares
Diluted Shares Outstanding 305.0M shares 311.0M shares 330.0M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $563.0M $554.0M $1.042B
YoY Change 3.11% -46.83% 65.92%
Cash & Equivalents $563.0M $554.0M $1.042B
Short-Term Investments
Other Short-Term Assets $316.0M $248.0M $264.0M
YoY Change 13.67% -6.06% 41.18%
Inventory
Prepaid Expenses
Receivables $2.565B $2.462B $2.112B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.444B $3.264B $3.418B
YoY Change 10.88% -4.51% 27.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.525B $1.595B $1.531B
YoY Change 64.82% 4.18% 3.31%
Goodwill $8.850B $8.904B $9.069B
YoY Change -0.78% -1.82% -0.42%
Intangibles
YoY Change
Long-Term Investments $311.0M $334.0M $361.0M
YoY Change -14.33% -7.48% -11.95%
Other Assets $822.0M $584.0M $575.0M
YoY Change 43.71% 1.57% -8.73%
Total Long-Term Assets $21.64B $21.60B $21.82B
YoY Change 0.62% -1.01% 0.57%
TOTAL ASSETS
Total Short-Term Assets $3.444B $3.264B $3.418B
Total Long-Term Assets $21.64B $21.60B $21.82B
Total Assets $25.09B $24.86B $25.24B
YoY Change 1.92% -1.49% 3.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $670.0M $722.0M $737.0M
YoY Change -13.32% -2.04% 37.76%
Accrued Expenses $2.584B $2.508B $2.328B
YoY Change 7.35% 7.73% -1.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $894.0M $358.0M $731.0M
YoY Change 60.22% -51.03% -11.07%
Total Short-Term Liabilities $7.520B $6.969B $6.422B
YoY Change 9.73% 8.52% 8.59%
LONG-TERM LIABILITIES
Long-Term Debt $10.40B $10.30B $8.738B
YoY Change 26.4% 17.86% -6.9%
Other Long-Term Liabilities $7.103B $1.711B $1.977B
YoY Change 278.83% -13.45% -15.66%
Total Long-Term Liabilities $17.51B $1.711B $1.977B
YoY Change 833.65% -13.45% -15.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.520B $6.969B $6.422B
Total Long-Term Liabilities $17.51B $1.711B $1.977B
Total Liabilities $25.31B $8.680B $8.399B
YoY Change 190.0% 3.35% 1.71%
SHAREHOLDERS EQUITY
Retained Earnings $13.54B $12.98B $10.68B
YoY Change 20.26% 21.47% 16.17%
Common Stock $5.957B $5.911B $5.836B
YoY Change 1.36% 1.29% 0.76%
Preferred Stock
YoY Change
Treasury Stock (at cost) $14.42B
YoY Change -0.31%
Treasury Stock Shares
Shareholders Equity -$224.0M $140.0M $1.772B
YoY Change
Total Liabilities & Shareholders Equity $25.09B $24.86B $25.24B
YoY Change 1.92% -1.49% 3.57%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $726.0M $757.0M $377.0M
YoY Change 7.08% 100.8% -3527.27%
Depreciation, Depletion And Amortization $70.00M $65.00M $72.00M
YoY Change 2.94% -9.72% 4.35%
Cash From Operating Activities $651.0M $887.0M $398.0M
YoY Change 0.15% 122.86% 1374.07%
INVESTING ACTIVITIES
Capital Expenditures $99.00M $95.00M $49.00M
YoY Change -241.43% 93.88% 63.33%
Acquisitions
YoY Change
Other Investing Activities -$85.00M -$6.000M -$19.00M
YoY Change -4350.0% -68.42% -371.43%
Cash From Investing Activities -$184.0M -$59.00M -$23.00M
YoY Change 170.59% 156.52% -20.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net $328.0M $401.0M
YoY Change -18.2% -46.68%
Cash From Financing Activities -459.0M -$782.0M -$729.0M
YoY Change -57.58% 7.27% 191.6%
NET CHANGE
Cash From Operating Activities 651.0M $887.0M $398.0M
Cash From Investing Activities -184.0M -$59.00M -$23.00M
Cash From Financing Activities -459.0M -$782.0M -$729.0M
Net Change In Cash 8.000M $46.00M -$354.0M
YoY Change -101.6% -112.99% 40.48%
FREE CASH FLOW
Cash From Operating Activities $651.0M $887.0M $398.0M
Capital Expenditures $99.00M $95.00M $49.00M
Free Cash Flow $552.0M $792.0M $349.0M
YoY Change -23.33% 126.93% -11733.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MARRIOTT INTERNATIONAL INC /MD/
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001048286
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13881
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2055918
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
7750 Wisconsin Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2023Q1 dei City Area Code
CityAreaCode
301
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
380-3000
CY2023Q1 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
MAR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
303354157 shares
CY2023Q1 us-gaap Revenues
Revenues
5615000000 usd
CY2022Q1 us-gaap Revenues
Revenues
4199000000 usd
CY2023Q1 mar Depreciation Amortizationand Other Excluding Capitalized Contract Cost Amortization
DepreciationAmortizationandOtherExcludingCapitalizedContractCostAmortization
44000000 usd
CY2022Q1 mar Depreciation Amortizationand Other Excluding Capitalized Contract Cost Amortization
DepreciationAmortizationandOtherExcludingCapitalizedContractCostAmortization
48000000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202000000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
208000000 usd
CY2023Q1 mar Business Combination Acquisition And Integration Related Costs And Other
BusinessCombinationAcquisitionAndIntegrationRelatedCostsAndOther
1000000 usd
CY2022Q1 mar Business Combination Acquisition And Integration Related Costs And Other
BusinessCombinationAcquisitionAndIntegrationRelatedCostsAndOther
9000000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
4664000000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
3641000000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
951000000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
558000000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4000000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
126000000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
93000000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
5000000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2000000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
844000000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
476000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
99000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
84000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
14000000 usd
CY2023Q1 mar Other Comprehensive Income Loss Other Adjustments After Reclassification And Tax Parent
OtherComprehensiveIncomeLossOtherAdjustmentsAfterReclassificationAndTaxParent
-2000000 usd
CY2022Q1 mar Other Comprehensive Income Loss Other Adjustments After Reclassification And Tax Parent
OtherComprehensiveIncomeLossOtherAdjustmentsAfterReclassificationAndTaxParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
839000000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
391000000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
554000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
507000000 usd
CY2023Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2462000000 usd
CY2022Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
2571000000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
248000000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
235000000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
3264000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
3313000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1595000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1585000000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
8904000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
8872000000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
17736000000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
17619000000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
334000000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
335000000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
126000000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
152000000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
240000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
240000000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
984000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
987000000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
584000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
584000000 usd
CY2023Q1 us-gaap Assets
Assets
24863000000 usd
CY2022Q4 us-gaap Assets
Assets
24815000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
358000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
684000000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
722000000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
746000000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1027000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1299000000 usd
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1481000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1296000000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6969000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7339000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
10299000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9380000000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
307000000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
313000000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1024000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1034000000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1711000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1842000000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5906000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5965000000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12975000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12342000000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
18099000000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
17015000000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-647000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-729000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
140000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
568000000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24863000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24815000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2023Q1 mar Depreciation Amortization And Other
DepreciationAmortizationAndOther
65000000 usd
CY2022Q1 mar Depreciation Amortization And Other
DepreciationAmortizationAndOther
72000000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
37000000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
44000000 usd
CY2023Q1 mar Noncash Income Tax Expense
NoncashIncomeTaxExpense
19000000 usd
CY2022Q1 mar Noncash Income Tax Expense
NoncashIncomeTaxExpense
61000000 usd
CY2023Q1 mar Increase Decreasein Capitalized Contract Costs Net
IncreaseDecreaseinCapitalizedContractCostsNet
-58000000 usd
CY2022Q1 mar Increase Decreasein Capitalized Contract Costs Net
IncreaseDecreaseinCapitalizedContractCostsNet
-26000000 usd
CY2023Q1 mar Noncash Merger Related And Restructuring Costs
NoncashMergerRelatedAndRestructuringCosts
0 usd
CY2022Q1 mar Noncash Merger Related And Restructuring Costs
NoncashMergerRelatedAndRestructuringCosts
7000000 usd
CY2023Q1 mar Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
-96000000 usd
CY2022Q1 mar Increase Decrease In Working Capital
IncreaseDecreaseInWorkingCapital
-230000000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
56000000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
36000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
887000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
398000000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
95000000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
49000000 usd
CY2023Q1 mar Payments For Loan Advances
PaymentsForLoanAdvances
1000000 usd
CY2022Q1 mar Payments For Loan Advances
PaymentsForLoanAdvances
0 usd
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
31000000 usd
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Notes Receivable
ProceedsFromSaleAndCollectionOfNotesReceivable
7000000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-6000000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-19000000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-23000000 usd
CY2023Q1 mar Proceeds From Repayments Of Commercial Paper And Long Term Lines Of Credit
ProceedsFromRepaymentsOfCommercialPaperAndLongTermLinesOfCredit
117000000 usd
CY2022Q1 mar Proceeds From Repayments Of Commercial Paper And Long Term Lines Of Credit
ProceedsFromRepaymentsOfCommercialPaperAndLongTermLinesOfCredit
-250000000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
783000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
328000000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
401000000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
124000000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1135000000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
72000000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
78000000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-23000000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-782000000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-729000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-354000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
525000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1421000000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
571000000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1067000000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
18000000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
17000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328300000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.44
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
309600000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
328300000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1400000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1700000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
311000000.0 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
330000000.0 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.43
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
33000000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42000000 usd
CY2023Q1 mar Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized
SharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognized
315000000 usd
CY2022Q4 mar Sharebased Compensation Nonvested Awards Compensation Cost Notyet Recognized
SharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognized
179000000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.103
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207
CY2023Q1 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
-99000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
156000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
255000000 usd
CY2023Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
145000000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
241000000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
68000000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
38000000 usd
CY2023Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
260000000 usd
CY2023Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
108000000 usd
CY2023Q1 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
1002000000 usd
CY2022Q4 us-gaap Commercial Paper Noncurrent
CommercialPaperNoncurrent
871000000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
137000000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
139000000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
56000000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
92000000 usd
CY2023Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
10657000000 usd
CY2022Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
10064000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
358000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
684000000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
10299000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
9380000000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
15000000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
29000000 usd
CY2023Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
4500000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.40
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
124000000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
81000000 usd
CY2023Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
-1000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
82000000 usd
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
14000000 usd
CY2022Q1 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
0 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000000 usd
CY2023Q1 mar Other Comprehensive Income Loss Foreign Currency Translation And Translation Gain Loss Before Reclassification And Tax Intra Entity Foreign Currency Transactions Long Term Investment Nature
OtherComprehensiveIncomeLossForeignCurrencyTranslationAndTranslationGainLossBeforeReclassificationAndTaxIntraEntityForeignCurrencyTransactionsLongTermInvestmentNature
-12000000 usd
CY2022Q1 mar Other Comprehensive Income Loss Foreign Currency Translation And Translation Gain Loss Before Reclassification And Tax Intra Entity Foreign Currency Transactions Long Term Investment Nature
OtherComprehensiveIncomeLossForeignCurrencyTranslationAndTranslationGainLossBeforeReclassificationAndTaxIntraEntityForeignCurrencyTransactionsLongTermInvestmentNature
12000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
568000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-34000000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1109000000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
140000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1414000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
14000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-33000000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1772000000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
194000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
191000000 usd
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
5615000000 usd
CY2022Q1 us-gaap Revenues
Revenues
4199000000 usd
CY2023Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-111000000 usd
CY2022Q1 us-gaap Interest Revenue Expense Net
InterestRevenueExpenseNet
-88000000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
87000000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
99000000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
757000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
377000000 usd

Files In Submission

Name View Source Status
mar-20230331_cal.xml Edgar Link unprocessable
0001628280-23-014793-index-headers.html Edgar Link pending
0001628280-23-014793-index.html Edgar Link pending
0001628280-23-014793.txt Edgar Link pending
0001628280-23-014793-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_0.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
image_0a.jpg Edgar Link pending
mar-20230331.htm Edgar Link pending
mar-20230331.xsd Edgar Link pending
mar-20230331_g1.jpg Edgar Link pending
mar-q12023xexx101.htm Edgar Link pending
mar-q12023xexx102.htm Edgar Link pending
mar-q12023xexx103.htm Edgar Link pending
mar-q12023xexx311.htm Edgar Link pending
mar-q12023xexx312.htm Edgar Link pending
mar-q12023xexx32.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
mar-20230331_def.xml Edgar Link unprocessable
mar-20230331_pre.xml Edgar Link unprocessable
mar-20230331_lab.xml Edgar Link unprocessable
mar-20230331_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending